Back
Explore every episode of the podcast Clinical Journal of the American Society of Nephrology (CJASN)
Dive into the complete episode list for Clinical Journal of the American Society of Nephrology (CJASN). Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Who Is at Risk? Advancing Kidney Health in Diverse Populations | 24 sept. 2026 | 00:16:55 | |
In this Editors' Choice Podcast, the CJASN EIC, Connie Rhee, and the Deputy Editors, Baback Roshanravan and Sagar Nigwekar, highlight three original research manuscripts focused on the theme of advancing kidney health equity in diverse populations. | |||
| Trends in Vascular Access Placement | 21 août 2026 | 00:04:56 | |
In this podcast, Dr. Allon and Dr. Lee summarize the main findings from their study on "Trends in Vascular Access Placement among Patients Initiating Hemodialysis with a Catheter" on behalf of their colleagues. | |||
| High-Volume Hemodiafiltration vs. Hemodialysis? New Data on Survival in Incident End-Stage Kidney Disease | 22 juil. 2026 | 00:02:49 | |
Drs. Ficociello, Zhang, & Kalantar-Zadeh summarize the main findings from their study, "Hemodialysis Modality and Mortality Outcomes among Incident Dialysis Patients: An International Cohort Study Comparing High-Volume Hemodiafiltration and Hemodialysis." | |||
| A Target Trial Emulation of GLP1RA, SGLT2i or DPP4i as Add on Treatment in CKD | 17 juin 2026 | 00:05:28 | |
In this podcast, Drs. Roumie and Hung summarize the main findings from their study on "Target Emulation Trial: GLP1RA, SGLT2i, DPP4i for Kidney Outcome Prevention" on behalf of their colleagues. | |||
| Total Kidney Volume and eGFR in Polycystic Kidney Disease | 18 mai 2026 | 00:03:54 | |
In this podcast, Dr. Yu summarizes the main findings from his study on the "Relationship between Total Kidney Volume and eGFR in Autosomal Dominant Polycystic Kidney Disease" on behalf of his colleagues. | |||
| Proteomic Markers of Dietary Patterns and Chronic Kidney Disease | 16 avr. 2026 | 00:04:50 | |
In this podcast, Dr. Rebholz summarizes the main findings from her study on "Proteomic Markers of Dietary Patterns, CKD Progression, and Mortality in the CRIC Study" on behalf of her colleagues. | |||
| Long-Term Results of the ILLUMINATE-A Trial of Lumasiran for Primary Hyperoxaluria Type 1 | 18 mars 2026 | 00:03:54 | |
Dr. Saland summarizes the main findings from his study on "Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1. | |||
| Finerenone and eGFR Slope | 26 févr. 2026 | 00:03:00 | |
Dr. McCausland summarizes the main findings from his study on "Effect of finerenone on eGFR slope across different levels of baseline albuminuria and eGFR: Insights from FINEARTS-HF" on behalf of his coauthors. | |||
| Dynamic Risk Prediction of Deceased Donor Kidney Transplant Failure | 18 févr. 2026 | 00:04:06 | |
Dr. Parikh, Dr. Malhotra, and Dr. Thiessen Philbrook summarize the main findings from their study on "Dynamic Risk Prediction of Graft Failure After Deceased Donor Kidney Transplant" on behalf of the authors. | |||
| Early-Start vs. Late-Start Icodextrin in Pediatric Peritoneal Dialysis Patients | 18 déc. 2025 | 00:06:20 | |
Drs. Dagmara Borzych-Dużałka and Khandelval summarize the main findings from their study on "Early-Start vs. Late-Start Icodextrin for Children Receiving Chronic Peritoneal Dialysis: Findings from the International Pediatric Peritoneal Dialysis Network". | |||
| Comparative Effectiveness of Lubiprostone and Stool Softeners in CKD | 28 oct. 2025 | 00:03:53 | |
In this podcast, Dr. Sumida summarizes the main findings from his study on "Comparative Effectiveness of Lubiprostone and Stool Softeners on Risk of Kidney Outcomes in Patients with CKD" on behalf of his coauthors. | |||
| SGLT2 Inhibition and Hospitalizations in Patients with Chronic Kidney Disease | 30 sept. 2025 | 00:03:47 | |
In this podcast, Dr. Neuen summarizes the main findings from his study on "SGLT2 inhibition and hospitalizations in patients with CKD: Data from CREDENCE and a meta-analysis of CKD progression trials" on behalf of his colleagues. | |||
| Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative Glomerulonephritis | 27 août 2025 | 00:03:09 | |
In this podcast, Dr. Ghaddar summarizes the main findings from her study on "Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative Glomerulonephritis" on behalf of her colleagues. | |||
| Perceptions of Future Earnings Among Nephrology Fellows | 25 juil. 2025 | 00:03:03 | |
In this podcast, Drs. Raslan and Triozzi summarize the main findings from their study on "Assessing Current Nephrology Fellows' Perceptions of Future Earnings as Attending Physicians" on behalf of their colleagues. | |||
| SGLT2 Inhibitors and Risk of Urinary Tract Infections with Abnormal Genitourinary Pathology | 27 juin 2025 | 00:07:23 | |
In this podcast, Drs. Eadon, Zhang, and Xu summarize the main findings from their study on "Risk of Urinary Tract Infections with SGLT2 Inhibitors in Subpopulations with Abnormal Genitourinary Pathology" on behalf of their colleagues. | |||
| Transition Practices in Pediatric and Adult Nephrology | 23 avr. 2025 | 00:03:41 | |
In this podcast, Dr. Vissing summarizes the main findings from his study on "Bridging the Gap: Assessing Nephrology Transition Practices in Pediatric and Adult Medical Centers" on behalf of his colleagues. | |||
| Creatinine and Cystatin-Based Equations in People with Cancer | 25 mars 2025 | 00:05:18 | |
In this podcast, Dr. Titan summarizes the main findings from her study on "Performance of creatinine and cystatin-based equations on estimating measured GFR in people with hematological and solid cancers" on behalf of her colleagues. | |||
| GLP1 Receptor Agonists and Kidney Outcomes | 14 févr. 2025 | 00:05:01 | |
In this podcast, Dr. Mendonça summarizes the main findings from his study on "The Impact of Glucagon-like Peptide-1 Receptor Agonists on Kidney Outcomes: A Meta-Analysis of Randomized Placebo-Controlled Trials" on behalf of his colleagues. | |||
| Anticoagulation and Fracture Risk in CKD Patients with Atrial Fibrillation | 23 janv. 2025 | 00:04:01 | |
In this podcast, Drs. Khan and Paik summarize the main findings from their study on "Fracture in association with anticoagulant therapy in patients with chronic kidney disease and atrial fibrillation" on behalf of their colleagues. | |||
| Comparing USRDS vs. National Death Index on Sudden Cardiac Death in Dialysis Patients | 23 déc. 2024 | 00:05:17 | |
In this podcast, Dr. Shafi and Dr. Obi summarize the main findings from their study on "Comparing USRDS and National Death Index Data on Sudden Cardiac Death in US Dialysis Patients" on behalf of their colleagues. | |||
| Association of Kidney Function with SGLT2 Inhibitor Discontinuation | 26 nov. 2024 | 00:04:05 | |
In this podcast, Dr. Estrella summarizes the main findings from her study on "Association of kidney function with SGLT2 inhibitor discontinuation among United States Veterans" on behalf of her colleagues. | |||
| Interview with 2024 CJASN Trainee of the Year – Second Place Awardee: Dr. Mohammad Azfar Qureshi | 15 nov. 2024 | 00:07:32 | |
In this podcast, CJASN Editor-in-Chief Dr. Rhee interviewed Dr. Qureshi on the findings of his study "The Association of Intra-abdominal Adhesions with Peritoneal Dialysis Catheter-Related Complications." | |||
| Interview with 2024 CJASN Trainee of the Year – First Place Awardee: Dr. Christine Limonte | 14 nov. 2024 | 00:05:53 | |
In this podcast, CJASN Editor-in-Chief Dr. Rhee interviewed Dr. Limonte on the findings of her study "Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes." | |||
| Providers' Experiences Discussing Alternatives to Kidney Replacement Therapy with Patients | 21 oct. 2024 | 00:05:25 | |
In this podcast, Drs. Wong and Chotivatanapong summarize the main findings from their study on "Nephrology Providers' Experiences Discussing Care for Patients with Kidney Failure who Forgo Kidney Replacement Therapy: National Qualitative Study" | |||
| Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management | 23 sept. 2024 | 00:17:49 | |
CJASN editors highlight three articles centered on the theme of CKD, including articles on SGLT2 inhibitors in CKD patients; SGLT2 inhibitors and cardiovascular death in CKD; and smartphone intervention for lifestyle and hypertension management in CKD. | |||
| Fellows' Perspectives on Parental Leave Policies and Family Planning | 16 août 2024 | 00:05:52 | |
In this podcast, Dr. Kendrick and Dr. Dixon summarize the main findings from their study on "A National Survey of Pregnancy and Parenthood Among Nephrology Trainees: A Focus on Nephrology Fellowship" on behalf of their colleagues. | |||
| Editors' Choice Articles: Pediatric ESKD iron stores, Impact of hemodiafiltration and hemodialysis on β-2-microglobulin, and Novel instruments for dialysis modality awareness | 01 août 2024 | 00:18:11 | |
Drs. Rhee, Roshanravan, and Nigwekar highlight three cutting-edge dialysis articles on pediatric ESKD iron store biomarkers; HDF, HD, and β-2-microglobulin kinetics; and development of a novel kidney replacement therapy awareness instrument. | |||
| Kidney Measures and Venous Thromboembolism | 14 déc. 2023 | 00:18:10 | |
Dr. Zhong Zheng provides an overview of his study, "Association of Estimated Glomerular Filtration Rate and Albuminuria with Venous Thromboembolism," on behalf of his colleagues. | |||
| Participant Experience in the KPMP - Spanish Language | 20 nov. 2023 | 00:05:50 | |
Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in Spanish. | |||
| Participant Experience in the KPMP | 20 nov. 2023 | 00:05:01 | |
Drs. Angela Maria Victoria-Castro and Celia Pamela Corona-Villalobos summarize the findings from their study, "Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project," in English. | |||
| Resveratrol in CKD | 20 nov. 2023 | 00:04:24 | |
Dr. Diana I. Jalal and Colin Gimblet discuss the findings of their study, "Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial," on behalf of their colleagues. | |||
| Tubular Biomarkers and Kidney Histopathology in Diabetes | 17 nov. 2023 | 00:03:21 | |
Dr. Christine Limonte summarizes the main findings from her study "Associations of Biomarkers of Tubular Injury and Inflammation with Biopsy Features in Type 1 Diabetes," on behalf of her colleagues. | |||
| Metabolomics and Neurocognition | 17 nov. 2023 | 00:03:34 | |
Dr. Arthur M. Lee provides an overview of the results of his study, "Circulating Metabolomic Associations with Neurocognitive Outcomes in Pediatric CKD," on behalf of his colleagues. | |||
| Interstitial Eosinophilic Aggregates Predict Kidney Failure | 10 nov. 2023 | 00:04:08 | |
Dr. Hattori Koki discusses the results of his study, "Interstitial Eosinophilic Aggregates and Kidney Outcome in Patients with CKD," on behalf of his colleagues. | |||
| Nurse Practitioner Care in CKD | 10 nov. 2023 | 00:04:38 | |
Dr. Matthew James, Ellen Novak, and Tayler Scory summarize the results of their study, "Nurse Practitioner Care Compared to Primary Care or Nephrologist Care in Early CKD," on behalf of their colleagues. | |||
| C3G Ig-MPGN and Complement Rare Variants | 08 nov. 2023 | 00:07:26 | |
Drs. Marie-Sophie Meuleman and Sophie Chauvet provide a summary of their study, "Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative Glomerulonephritis," on behalf of their colleagues. | |||
| Cardiovascular Prevention in CKD | 08 nov. 2023 | 00:04:46 | |
Dr. Reza Malekzadeh gives an overview of the results of his article "Fixed-Dose Combination Therapy for Prevention of Cardiovascular Diseases in CKD: An Individual Participant Data Meta-Analysis," on behalf of his colleagues. | |||
| An Interview with Tristan de Nattes, the Second-Place Winner of the 2023 CJASN Trainee of the Year Competition | 02 nov. 2023 | 00:05:48 | |
CJASN Editor-in-Chief Rajnish Mehrotra interviews Tristan de Nattes, the 2023 CJASN Trainee of the Year second-place winner, on his article, "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies." | |||
| An Interview with Rosa D. Wouda, the First-Place Winner of the 2023 CJASN Trainee of the Year Competition | 02 nov. 2023 | 00:06:02 | |
CJASN Editor-in-Chief Rajnish Mehrotra interviews 2023 CJASN Trainee of the Year winner Rosa D. Wouda on her article, "Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements." | |||
| HPA Axis Suppression in Nephrotic Syndrome | 09 oct. 2023 | 00:03:24 | |
Dr. Rajiv Sinha discusses the findings from his study, "HPA Axis in Single- versus Divided-Dose Prednisolone for First Episode Nephrotic Syndrome: An Open Label RCT," on behalf of his colleagues. | |||
| PLA2R Antibodies and Treatment Response | 09 oct. 2023 | 00:04:43 | |
Drs. Daniel Cattran and Sean Barbour summarize the main results of their study, "Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy," on behalf of their colleagues. | |||
| eGFRcys and eGFRcr Discrepancy | 08 sept. 2023 | 00:05:33 | |
Dr. Morgan Grams provides an overview of the findings of her study, "Discrepancies between Cystatin C–Based and Creatinine-Based Estimated Glomerular Filtration Rates," on behalf of her colleagues. | |||
| Dasatinib Nephrotoxicity and Pharmacokinetics | 08 sept. 2023 | 00:04:07 | |
Drs. Benjamin Adegbite and Evren Azeloglu discuss the results of their study, "Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity," on behalf of their colleagues. | |||
| Timing KRT in Children and Young Adults | 08 août 2023 | 00:03:13 | |
Dr. Nick Larkins discusses the findings of his study, "Timing of Kidney Replacement Therapy among Children and Young Adults," on behalf of his colleagues. | |||
| COVID-19–Associated AKI | 08 août 2023 | 00:05:19 | |
Dr. Farrukh M. Koraishy summarizes the results of his study, "Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative," on behalf of his colleagues. | |||
| ICI-Induced Kidney Adverse Events | 10 juil. 2023 | 00:03:18 | |
Dr. Gangadharan Komala provides a summary of the results of his study, "Kidney Adverse Events Associated with Immune Checkpoint Inhibitor Therapy," on behalf of his colleagues. | |||
| Nirmatrelvir/Ritonavir in Kidney Transplant Patients | 10 juil. 2023 | 00:04:31 | |
Mr. Pierre Giguère and Dr. Swapnil Hiremath provide an overview of their study, "Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients," on behalf of their colleagues. | |||
| Kidney Stone Events after Kidney Transplant | 08 juin 2023 | 00:04:30 | |
Drs. Calyani Ganesan, Alan Pao, and John Leppert discuss the results of their study, "Kidney Stone Events after Kidney Transplant in the United States," on behalf of their colleagues. | |||
| Albuminuria and Outcomes with Canagliflozin | 08 juin 2023 | 00:06:29 | |
Dr. Hiddo J.L. Heerspink summarizes the findings of his study, "Glycemic Control and Effects of Canagliflozin in Reducing Albuminuria and eGFR," on behalf of his colleagues. | |||
| COVID-19 or Vaccinated Patients' Kidney Biopsies | 08 mai 2023 | 00:04:45 | |
Drs. Maria de las Mercedes Noriega and Faeq Husain-Syed discuss the results of their study "Kidney Biopsy Findings in Patients with SARS-CoV-2 Infection or After COVID-19 Vaccination," on behalf of their colleagues. | |||
© My Podcast Data · Independent project · Data from Apple & Spotify